Ramipril Reduces Sudden Cardiac Arrest in Patients Without Heart Failure

"The angiotensin-converting enzyme (ACE) inhibitor ramipril decreases risk of sudden cardiac arrest and nonfatal serious arrhythmic events in patients without left ventricular dysfunction, according to an analysis of the Heart Outcomes Prevention Evaluation (HOPE) trial results published in the Sept. 14 issue of Circulation and posted online Sept. 7 as a rapid access publication"